CDK1 and neoplasm: Moreover, CDK2 has been reported to be essential for cell proliferation in several human tumours [4–6, 21] and emerging data have suggested that CDK1 or CDK2 can be considered as the most appropriate CDKs to target in combination with DNA-damaging agents [15].